Gil Ben-Menachem

Plus aucun poste en cours

56 ans

Health Technology

Consumer Services

Profil

Gil Ben-Menachem served as Chief Executive Officer at OphthaliX, Inc. in 2013.
Prior to that, he was Director of Business Development at Teva Pharmaceutical Industries Ltd., Head of Innovative Products at Dexcel Pharma Technologies Ltd., and Vice President of Business Development at Purple Biotech Ltd.
Ben-Menachem holds a Master's in Business Administration from the University of Maryland and undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.

Anciens postes connus de Gil Ben-Menachem

Sociétés	Poste	Fin
OphthaliX, Inc. OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel.	President	25/02/2013
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	-
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Corporate Officer/Principal	-
PURPLE BIOTECH LTD	Directeur/Membre du Conseil	-

Voir l'expérience en détail de Gil Ben-Menachem

Formation de Gil Ben-Menachem

The Hebrew University of Jerusalem	Doctorate Degree
University of Maryland	Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées